MarketVIEW - Chlamydia trachomatis vaccines

  • June 2012
  • -
  • VacZine Analytics Group Of Assay Advantage Ltd

Chlamydia trachomatis (CT) is an intracellular Gram-negative bacterium and a leading cause worldwide of sexually-transmitted disease and preventable blindness. The pathogen is a major cause of serious reproductive complications in the female with outcomes such as pelvic inflammatory disease (PID) and ectopic pregnancies.

Although diagnosed infections with Chlamydia trachomatis are curable with antibiotic therapy the vast majority infections are "silent" and unrecognized. This is of concern due to continued transmission especially among individuals below 30 years of age. Prophylatic vaccines could prevent CT primary infection, reinfection or lessen the incidence and severity of PID, or similar long-term sequelae. A key question for vaccine manufacturers is whether a CT vaccine would be deployed alongside HPV vaccines in the preadolescent population, thus providing a sizeable commercial opportunity.

This MarketVIEW product gives a comprehensive vaccine value ($USD/volume (000s) forecast for a putative CT vaccine until 2035. The model includes LO/BASE/HI forecast scenarios so the user can visualize the commercial impact of differing targetting/competitive and pricing scenarios. This product is an essential component of any commercial opportunistic assessment focused on new adolescent vaccines.

THIS PRODUCT IS A SUMMARY PRESENTATION + MODEL

Table Of Contents

MarketVIEW - Chlamydia trachomatis vaccines
Contents - Summary presentation (MS PowerPoint based)

Executive Summary
Commercial model - key outputs
Total available demand: Chlamydia vaccine, global, (000s doses)
Total available demand: Chlamydia vaccine, high-income markets, (000s doses)
Total available demand: Chlamydia vaccine, emerging markets, (000s doses)
Total available market: Chlamydia vaccine, global, ($ 000s)
Total available market: Chlamydia vaccine, by market, ($ 000s)
Total available market: Chlamydia vaccine, price sensitivity analysis, ($ 000s)
Chlamydia vaccine: country volume analysis, 2025 (000s doses)
Chlamydia vaccine: country value analysis, 2025 ($ 000s)
The role of a CT vaccine
Commercial model - key assumptions
Pricing
Model forecast comparisons: June 2011 v current
Chlamydia vaccine opportunity: target product profile
Overall commercial model assumptions per country
Chlamydia trachomatis: brief background
Clinical features
Chlamydia trachomatis: natural history of infection
Chlamydia trachomatis: global incidence
Chlamydia trachomatis: global prevalence
US epidemiology
UK epidemiology
Reasons for increasing incidence
Potential impact of a CT vaccine
Competitor landscape: overview
Competitive environment: major players
Chlamydia trachomatis vaccine - HPV, a relevant case study?
HPV vaccines: analysis of country uptake
Bibliography
Disclaimer
About VacZine Analytics

PAGES: ~57 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form

Contents - Vaccine demand model (MS Excel-based)

Title Sheet
Scenario definition
Value Scenario Analysis
Value Summary (Western)
Volume Summary (Western)
Value Summary (Emerging)
Volume Summary (Emerging)
Charts - volume (Western)
Charts - value (Western)
Charts - value/volume (Western)
Females (Western)
US (13 yrs/ 14 - 18 yrs)
Canada
UK
France
Germany
Italy
Spain
Other EU
Australia
Japan
Females (Emerging)
Brazil
Russia
India
China
Mexico
Population database
Competition - IP landscape
Assumptions - major markets
Back page
About VacZine Analytics
Disclaimer

WORKSHEETS: ~65

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound ...

Analysis of the Global Vaccines Delivery Market : Innovative Technologies and Future Trends for Stakeholders

Analysis of the Global Vaccines Delivery Market : Innovative Technologies and Future Trends for Stakeholders

  • $ 6 500
  • Industry report
  • March 2015
  • by Frost & Sullivan

Methodology The analysis in this research service is based on the following: •Information collected through discussions with market participants. •Information from secondary pharmaceutical companies, ...

Foot and Mouth Disease (FMD) Vaccines Market (By Types: Conventional Vaccines and Emergency Vaccines, and By Applications: Cattle, Pigs, Sheep and Goats and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Foot and Mouth Disease (FMD) Vaccines Market (By Types: Conventional Vaccines and Emergency Vaccines, and By Applications: Cattle, Pigs, Sheep and Goats and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • $ 4 795
  • Industry report
  • January 2015
  • by Transparency Market Research

Foot-and-mouth disease (FMD) is an infection caused by aphthovirus belonging to the family Picornaviridae. FMD is caused by seven different types of serotypes: O, A, C, Asia 1 and Southern African Territories ...


Download Unlimited Documents from Trusted Public Sources

Tobacco Production in the US

  • April 2015
    32 pages
  • Tobacco Product...  

    Tobacco  

    Cancer  

  • United States  

    North America  

    Puerto Rico  

View report >

Vaccine Industry in India - Forecast

  • April 2015
    7 pages
  • Vaccine  

    Cold Chain  

  • India  

View report >

Pathology Description

  • April 2015
    68 pages
  • Cardiovascular ...  

    Indigestion Dru...  

    Anti-Infective  

View report >

Related Market Segments :

Vaccine
Chlamydia

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.